- SG$1.14bn
- SG$2.19bn
- SG$351.15m
- 26
- 17
- 63
- 24
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 65.22 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.17 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.91 | ||
| EV to EBITDA | 20.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.6% | ||
| Return on Equity | 0.1% | ||
| Operating Margin | 17.72% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 327.8 | 240.4 | 333.71 | 355.77 | 351.15 | 414.05 | 452.5 | 10.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +275.93 | -31.53 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Thomson Medical Group Limited is a Singapore-based company engaged in investments, investment holdings and strategic investments and other related activities. The Company’s subsidiaries are engaged in operating hospitals and clinics, and provision of healthcare services. Its segments include Singapore, Malaysia, Vietnam, and investment holdings. It is engaged in the provision of integrated medical healthcare facilities and services for primary, secondary and tertiary healthcare with a focus on obstetrics and gynecology and pediatric services, diagnostic imaging services, pharmacy, 24-hour outpatient services, laboratory and services provided by outpatient clinics at the hospital. Its specialized services include services provided by fertility clinics, pediatric centers, cancer centers, cardiology centers, Traditional Chinese Medicine, and others. Its brands include Thomson Women's Clinic, Thomson Paediatric Clinic, Thomson Specialists, Thomson Fertility Centre, and others.
Directors
- Ser Miang Ng NEC (72)
- Chiang Yin Wong CEO (53)
- Wilson Sam CFO (45)
- Wei Ling Chan CEX
- Yu Chee Wong CEX (44)
- Zing Yuen Tan CCO (65)
- Hsien Chieh Lee GMG
- Wan Nadiah Binti Wan Mohd Abdullah Yaakob EDR (37)
- Wee Kiat Lim EDR (28)
- Soon Soo Foo SEC
- Hoi Leong Lim SEC
- Lee Lam NID (62)
- Lai Ling Leong NID (47)
- Pang Liang Ong NID (62)
- Tze Wei Teo NID (48)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 31st, 1999
- Public Since
- July 8th, 2002
- No. of Shareholders
- 8,306
- No. of Employees
- 669
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Singapore Exchange Securities Trading Ltd- Shares in Issue
- 26,441,067,000
- Address
- 101 Thomson Road, 307591
- Web
- https://www.thomsonmedical.com/
- Phone
- +65 63310188
- Auditors
- Ernst & Young LLP
Upcoming Events for A50
Similar to A50
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 23:40 UTC, shares in Thomson Medical are trading at SG$0.04. This share price information is delayed by 15 minutes.
Shares in Thomson Medical last closed at SG$0.04 and the price had moved by -17.65% over the past 365 days. In terms of relative price strength the Thomson Medical share price has underperformed the FTSE Developed Asia Pacific Index by -16.71% over the past year.
The overall consensus recommendation for Thomson Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThomson Medical does not currently pay a dividend.
Thomson Medical does not currently pay a dividend.
Thomson Medical does not currently pay a dividend.
To buy shares in Thomson Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$0.04, shares in Thomson Medical had a market capitalisation of SG$1.14bn.
Here are the trading details for Thomson Medical:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: A50
Based on an overall assessment of its quality, value and momentum Thomson Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Thomson Medical is SG$0.05. That is 13.95% above the last closing price of SG$0.04.
Analysts covering Thomson Medical currently have a consensus Earnings Per Share (EPS) forecast of -SG$0.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Thomson Medical. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -9.17%.
As of the last closing price of SG$0.04, shares in Thomson Medical were trading -10.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Thomson Medical PE ratio based on its reported earnings over the past 12 months is 65.22. The shares last closed at SG$0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Thomson Medical's management team is headed by:
- Ser Miang Ng - NEC
- Chiang Yin Wong - CEO
- Wilson Sam - CFO
- Wei Ling Chan - CEX
- Yu Chee Wong - CEX
- Zing Yuen Tan - CCO
- Hsien Chieh Lee - GMG
- Wan Nadiah Binti Wan Mohd Abdullah Yaakob - EDR
- Wee Kiat Lim - EDR
- Soon Soo Foo - SEC
- Hoi Leong Lim - SEC
- Lee Lam - NID
- Lai Ling Leong - NID
- Pang Liang Ong - NID
- Tze Wei Teo - NID